$LMFA
LM FUNDING AMERICA, INC. Stock $lmfa

$lmfa Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000156459022013045 Filed on March 31, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$197.6K	$898.9K	$330.0K
YoY Change	-40.11%	-28.86%	-35.29%
Cost Of Revenue	$930.9K	$2.272M	$430.0K
YoY Change	116.49%	26.21%	30.3%
Gross Profit	-$733.3K	$12.44M	-$100.0K
YoY Change	633.27%	-2404.63%	-155.56%
Gross Profit Margin	-371.03%	1384.41%	-30.3%
Selling, General & Admin	$3.433M	$7.256M	$380.0K
YoY Change	803.3%	85.11%	-28.3%
% of Gross Profit		58.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	-$8.100K	$1.383K	$0.00
YoY Change		-87.59%	-100.0%
% of Gross Profit		0.01%
Operating Expenses	$3.434M	$9.331M	$200.0K
YoY Change	1617.07%	75.55%	-41.18%
Operating Profit	-$4.167M	$3.114M	-$300.0K
YoY Change	1289.13%	-153.17%	87.5%
Interest Expense	-$817.4K	-$193.5K	$0.00
YoY Change		-2791.47%	-100.0%
% of Operating Profit		-6.21%
Other Income/Expense, Net
YoY Change
Pretax Income	-$4.983M	$5.329M	-$300.0K
YoY Change	1561.02%	-231.29%	-83.78%
Income Tax	$296.3K	$326.2K
% Of Pretax Income		6.12%
Net Earnings	-$5.238M	$4.759M	-$300.0K
YoY Change	1646.16%	-217.76%	-83.52%
Net Earnings / Revenue	-2650.66%	529.42%	-90.91%
Basic Earnings Per Share		$0.70
Diluted Earnings Per Share	-$458.1K	$0.60	-$97.09K
COMMON SHARES
Basic Shares Outstanding		6.829M
Diluted Shares Outstanding		7.927M

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.23M	$35.23M	$11.55M
YoY Change	205.03%	205.03%	979.44%
Cash & Equivalents	$32.56M		$11.55M
Short-Term Investments	$2.671M	$2.671M
Other Short-Term Assets	$1.252M	$1.252M	$400.0K
YoY Change	212.96%	212.96%	166.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$38.51M	$38.51M	$12.12M
YoY Change	217.72%	217.74%	583.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$17.91K	$77.88K	$6.171K
YoY Change	190.29%	-54.19%	-25.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.973M	$6.650M	$20.00K
YoY Change	9767.07%	33147.7%	-98.68%
Other Assets	$10.73K	$16.87M	$10.98K
YoY Change	-2.35%	168558.8%	-0.34%
Total Long-Term Assets	$23.59M	$23.59M	$196.6K
YoY Change	11901.34%	11696.66%	-96.65%
TOTAL ASSETS
Total Short-Term Assets	$38.51M	$38.51M	$12.12M
Total Long-Term Assets	$23.59M	$23.59M	$196.6K
Total Assets	$62.10M	$62.10M	$12.32M
YoY Change	404.2%	404.09%	61.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$121.2K	$121.2K	$160.0K
YoY Change	-24.24%	-24.24%	-54.29%
Accrued Expenses	$68.00K	$68.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$114.7K	$114.7K	$96.26K
YoY Change	19.15%	14.69%	38.42%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.094M	$1.094M	$491.7K
YoY Change	122.44%	123.21%	-88.06%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$190.0K
YoY Change	-100.0%	-100.0%	-63.46%
Other Long-Term Liabilities	$0.00	$0.00	$170.0K
YoY Change	-100.0%	-100.0%	-37.04%
Total Long-Term Liabilities	$0.00	$0.00	$253.8K
YoY Change	-100.0%	-100.0%	-63.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.094M	$1.094M	$491.7K
Total Long-Term Liabilities	$0.00	$0.00	$253.8K
Total Liabilities	$1.094M	$1.343M	$849.1K
YoY Change	28.81%	57.98%	-82.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.78M		-$18.54M
YoY Change	-25.68%		27.88%
Common Stock	$74.54M		$30.00M
YoY Change	148.47%		73.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$60.76M	$60.76M	$11.46M
YoY Change
Total Liabilities & Shareholders Equity	$62.10M	$62.10M	$12.32M
YoY Change	404.2%	404.09%	61.21%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$5.238M	$4.759M	-$300.0K
YoY Change	1646.16%	-217.76%	-83.52%
Depreciation, Depletion And Amortization	-$8.100K	$1.383K	$0.00
YoY Change		-87.59%	-100.0%
Cash From Operating Activities	-$1.787M	$3.487M	-$720.0K
YoY Change	148.23%	-198.98%	188.0%
INVESTING ACTIVITIES
Capital Expenditures	-$10.20K	-$14.41K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$15.20M	-$23.95M	$90.00K
YoY Change	-16992.96%	-1751.71%	-106.25%
Cash From Investing Activities	-$15.21M	-$23.96M	$90.00K
YoY Change	-17004.29%	-1752.04%	-106.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$31.46M
YoY Change		232.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.10M	41.48M	-50.00K
YoY Change	-64303.08%	230.39%	-16.67%
NET CHANGE
Cash From Operating Activities	-1.787M	3.487M	-720.0K
Cash From Investing Activities	-15.21M	-23.96M	90.00K
Cash From Financing Activities	32.10M	41.48M	-50.00K
Net Change In Cash	15.10M	21.01M	-680.0K
YoY Change	-2320.65%	100.38%	-61.36%
FREE CASH FLOW
Cash From Operating Activities	-$1.787M	$3.487M	-$720.0K
Capital Expenditures	-$10.20K	-$14.41K	$0.00
Free Cash Flow	-$1.777M	$3.502M	-$720.0K
YoY Change	146.82%	-199.39%	188.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q2	lmfa	Reverse Stock Split Percentage Of Issued Common Stock ReverseStockSplitPercentageOfIssuedCommonStock	0.2
CY2020Q2	lmfa	Reverse Stock Split Percentage Of Issued Common Stock ReverseStockSplitPercentageOfIssuedCommonStock	0.1
CY2020Q2	lmfa	Reverse Stock Split Percentage Of Outstanding Common Stock ReverseStockSplitPercentageOfOutstandingCommonStock	0.5
CY2021Q4	us-gaap	Real Estate Investments Other RealEstateInvestmentsOther	80057
CY2020Q4	us-gaap	Real Estate Investments Other RealEstateInvestmentsOther	18767
CY2021	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	0
CY2021Q2	lmfa	Reverse Stock Split Percentage Of Issued Common Stock ReverseStockSplitPercentageOfIssuedCommonStock	1
CY2021Q4	us-gaap	Real Estate Investments Other RealEstateInvestmentsOther	80057
CY2020Q4	us-gaap	Real Estate Investments Other RealEstateInvestmentsOther	18767
CY2021	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	0
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAsset
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	103646
CY2021Q4	us-gaap	Debt Securities Current DebtSecuritiesCurrent	539351
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	886543
CY2021	lmfa	Interest Income InterestIncome	211427
CY2021	lmfa	Interest Income Expense InterestIncomeExpense	-653
CY2021	dei	Auditor Firm AuditorFirmId	206
CY2021	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2021	dei	Auditor Location AuditorLocation	Houston, Texas
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2132051
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	2000000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160667
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4676130
CY2021Q4	lmfa	Deposit On Mining Equipment Noncurrent DepositOnMiningEquipmentNoncurrent	16775100
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10726
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	23593309
CY2021Q4	us-gaap	Assets Assets	62103941
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	114688
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	237033
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	326178
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	185785
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68002
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	253787
CY2020Q4	us-gaap	Liabilities Liabilities	849122
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12317430
CY2021	lmfa	Administrative And Late Fees AdministrativeAndLateFees	69369
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	3083
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	29996258
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18536224
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11463117
CY2020Q4	us-gaap	Minority Interest MinorityInterest	5191
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11468308
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	150000000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3083760
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3083760
CY2021	lmfa	Recoveries On Collection Of Assessments In Excess Of Cost RecoveriesOnCollectionOfAssessmentsInExcessOfCost	95904
CY2020	lmfa	Recoveries On Collection Of Assessments In Excess Of Cost RecoveriesOnCollectionOfAssessmentsInExcessOfCost	214558
CY2021	lmfa	Underwriting Fees And Other Revenues UnderwritingFeesAndOtherRevenues	120176
CY2020	lmfa	Underwriting Fees And Other Revenues UnderwritingFeesAndOtherRevenues	116430
CY2021	lmfa	Rental Revenue RentalRevenue	141569
CY2020	lmfa	Rental Revenue RentalRevenue	206831
CY2021	us-gaap	Revenues Revenues	898941
CY2020	us-gaap	Revenues Revenues	1263602
CY2021	lmfa	Real Estate Management And Disposal RealEstateManagementAndDisposal	132283
CY2020	lmfa	Real Estate Management And Disposal RealEstateManagementAndDisposal	211288
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11087
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16930
CY2021	lmfa	Collection Cost CollectionCost	4459
CY2020	lmfa	Collection Cost CollectionCost	-29932
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	200000
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	500000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	50800
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11143
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.50
CY2021	lmfa	Right To Use Asset Expense RightToUseAssetExpense	100698
CY2020	lmfa	Right To Use Asset Expense RightToUseAssetExpense	99593
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	219667
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	125450
CY2021	lmfa	Stock Option Expense1 StockOptionExpense1	2323118
CY2020	lmfa	Stock Option Expense1 StockOptionExpense1	14939
CY2021	lmfa	Share Based Compensation Employees ShareBasedCompensationEmployees	292500
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	74520
CY2020	lmfa	Allowance For Doubtful Accounts Receivable Recoveries Related Party AllowanceForDoubtfulAccountsReceivableRecoveriesRelatedParty	300000
CY2020	lmfa	Reserve For Units ReserveForUnits	30000
CY2021	lmfa	Debt Forgiveness DebtForgiveness	157250
CY2021	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	224678
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	17778
CY2021	us-gaap	Operating Expenses OperatingExpenses	9331320
CY2020	us-gaap	Operating Expenses OperatingExpenses	5315612
CY2021	lmfa	Realized Gain On Securities RealizedGainOnSecurities	13817863
CY2021	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-407992
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1387590
CY2021	lmfa	Realized Gain On Digital Assets RealizedGainOnDigitalAssets	502657
CY2021	lmfa	Impairment Gain Loss On Digital Assets ImpairmentGainLossOnDigitalAssets	-19945
CY2020	lmfa	Interest Income Expense InterestIncomeExpense	-7189
CY2021	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2113
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	157250
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5329294
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4059199
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326178
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	5003116
CY2020	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4059199
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	16428
CY2021	us-gaap	Profit Loss ProfitLoss	5003116
CY2020	us-gaap	Profit Loss ProfitLoss	-4042771
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	243898
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1309
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4759218
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-4041462
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.70
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.50
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.01
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.49
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.60
CY2020	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.01
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.49
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6828704
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1622911
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7927255
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1622911
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2834925
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	125450
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	14939
CY2020	lmfa	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	3081730
CY2020	lmfa	Stock Issued During Period Value New Issues In Noncontrolling Interest StockIssuedDuringPeriodValueNewIssuesInNoncontrollingInterest	6500
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1250000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11468308
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2323118
CY2021	lmfa	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	10247124
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	219667
CY2021	lmfa	Share Based Compensation Employees ShareBasedCompensationEmployees	292500
CY2021	us-gaap	Profit Loss ProfitLoss	5003116
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	61010207
CY2021	us-gaap	Profit Loss ProfitLoss	5003116
CY2020	us-gaap	Profit Loss ProfitLoss	-4042771
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1383
CY2021	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	43623
CY2021	lmfa	Impairment Gain Loss On Digital Assets ImpairmentGainLossOnDigitalAssets	-19945
CY2021	lmfa	Unrealized Gain Loss On Convertible Debt Securities UnrealizedGainLossOnConvertibleDebtSecurities	-407992
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1387590
CY2021	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	886543
CY2021	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	13817863
CY2021	lmfa	Realized Gain On Sale Of Digital Assets RealizedGainOnSaleOfDigitalAssets	502657
CY2021	lmfa	Proceeds From Securities Operating Activities ProceedsFromSecuritiesOperatingActivities	30400433
CY2021	lmfa	Investment In Convertible Note Receivable Converted Into Marketable Security InvestmentInConvertibleNoteReceivableConvertedIntoMarketableSecurity	16582571
CY2021	lmfa	Investment In Convertible Note Receivable InvestmentInConvertibleNoteReceivable	5000000
CY2021	lmfa	Convertible Debt And Interest Converted Into Marketable Securities ConvertibleDebtAndInterestConvertedIntoMarketableSecurities	4231758
CY2021	lmfa	Investment In Marketable Securities InvestmentInMarketableSecurities	3651400
CY2020	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	16428
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	845853
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	61303
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	89235
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	583444
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	349644
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	126950
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	103646
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	94235
CY2021	lmfa	Increase Decrease In Deferred Taxes And Taxes Payable IncreaseDecreaseInDeferredTaxesAndTaxesPayable	326178
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3487331
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3523218
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	14411
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1286
CY2020	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	246914
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2000000
CY2021	lmfa	Payment To Acquire Digital Assets PaymentToAcquireDigitalAssets	1419958
CY2021	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	1902670
CY2021	lmfa	Loan To Purchase Securities LoanToPurchaseSecurities	1784250
CY2021	lmfa	Repayment Of Loan To Purchase Securities RepaymentOfLoanToPurchaseSecurities	1784250
CY2021	lmfa	Payments To Deposits For Mining Equipment PaymentsToDepositsForMiningEquipment	16775100
CY2021	lmfa	Payments To Acquire Investment In Unconsolidated Affiliate PaymentsToAcquireInvestmentInUnconsolidatedAffiliate	5738000
CY2020	lmfa	Proceeds From Investment In Note Receivable ProceedsFromInvestmentInNoteReceivable	1500000
CY2021	lmfa	Proceeds From Underwriting And Origination Fees ProceedsFromUnderwritingAndOriginationFees	-60006
CY2020	lmfa	Proceeds From Underwriting And Origination Fees ProceedsFromUnderwritingAndOriginationFees	-5423
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23964224
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1450586
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	185785
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	220363
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	165798
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	10247124
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3081730
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31456374
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9447535
CY2020	lmfa	Investments In Subsidiaries InvestmentsInSubsidiaries	6500
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41483135
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12555752
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	21006242
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	10483120
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11552943
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1069823
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32559185
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11552943
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1892
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7189
CY2021	lmfa	Noncash Investing And Financing Activities Insurance Financing NoncashInvestingAndFinancingActivitiesInsuranceFinancing	210260
CY2020	lmfa	Noncash Investing And Financing Activities Insurance Financing NoncashInvestingAndFinancingActivitiesInsuranceFinancing	192514
CY2021Q4	lmfa	Number Of Subsidiaries Created NumberOfSubsidiariesCreated	2
CY2021	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5414296
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Use of Estimates </span></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s <span style="font-style:italic;">New Neighbor Guaranty</span> program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation, fair value estimates of real estate assets owned and reserves on notes receivables. </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.</p>
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4658226
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3246467
CY2021Q4	lmfa	Capitalized Real Estate Costs Accumulated Depreciation Net CapitalizedRealEstateCostsAccumulatedDepreciationNet	80057
CY2020Q4	lmfa	Capitalized Real Estate Costs Accumulated Depreciation Net CapitalizedRealEstateCostsAccumulatedDepreciationNet	18767
CY2020	lmfa	Purchase Of Insurance Policies PurchaseOfInsurancePolicies	192514
CY2021	lmfa	Purchase Of Insurance Policies PurchaseOfInsurancePolicies	210260
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	74000
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	258000
CY2021	lmfa	Debt Instrument Amount Funded For Transaction DebtInstrumentAmountFundedForTransaction	1666667
CY2021	lmfa	Part Of Transaction Purchased Amount PartOfTransactionPurchasedAmount	3333333
CY2021Q2	lmfa	Stock Issued Shares For Warrants Exercised StockIssuedSharesForWarrantsExercised	5956544
CY2021Q2	lmfa	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	8500000
CY2021	lmfa	Marketable Securities Shares Sold MarketableSecuritiesSharesSold	1064935
CY2021	lmfa	Shares Classified As Marketable Securities SharesClassifiedAsMarketableSecurities	4895894
CY2021Q1	lmfa	Gain Loss On Loan Agreement GainLossOnLoanAgreement	5700000
CY2021Q1	lmfa	Amount Of Loans Receivables Acquired AmountOfLoansReceivablesAcquired	18200000
CY2021Q1	lmfa	Cost Associated With Acquisition Of Receivables Loan CostAssociatedWithAcquisitionOfReceivablesLoan	15500000
CY2021Q1	lmfa	Proceeds From Sale Of Own Shares ProceedsFromSaleOfOwnShares	32600000
CY2021Q1	lmfa	Provision For Investor ProvisionForInvestor	11300000
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4766349
CY2021Q4	lmfa	Available For Sale Securities Cost Of Shares Sold AvailableForSaleSecuritiesCostOfSharesSold	-1246708
CY2021Q4	lmfa	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Loss AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainLoss	-1387590
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	2132051
CY2021	lmfa	Impairment Gain Loss On Digital Assets ImpairmentGainLossOnDigitalAssets	-20000
CY2021	lmfa	Gain Loss On Disposition Of Digital Assets GainLossOnDispositionOfDigitalAssets	503000
CY2021Q4	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	2
CY2020Q4	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	1
CY2021	lmfa	Number Of Units In Real Estate Property Capitalized NumberOfUnitsInRealEstatePropertyCapitalized	1
CY2020	lmfa	Number Of Units In Real Estate Property Capitalized NumberOfUnitsInRealEstatePropertyCapitalized	0
CY2021	lmfa	Real Estate Investment Capitalized RealEstateInvestmentCapitalized	0
CY2020	lmfa	Real Estate Investment Capitalized RealEstateInvestmentCapitalized	0
CY2021Q4	lmfa	Real Estate Portfolio Number Of Units As Result Of Foreclosure Action RealEstatePortfolioNumberOfUnitsAsResultOfForeclosureAction	8
CY2020Q4	lmfa	Real Estate Portfolio Number Of Units As Result Of Foreclosure Action RealEstatePortfolioNumberOfUnitsAsResultOfForeclosureAction	8
CY2021	lmfa	Number Of Real Estate Properties Sold NumberOfRealEstatePropertiesSold	1
CY2020	lmfa	Number Of Real Estate Properties Sold NumberOfRealEstatePropertiesSold	12
CY2020	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	73000
CY2021	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0
CY2020	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	0
CY2021	lmfa	Rental Income From Real Estate RentalIncomeFromRealEstate	142000
CY2021	lmfa	Cost Recovery From Real Estate Assets Owned Rent Revenue CostRecoveryFromRealEstateAssetsOwnedRentRevenue	0
CY2020	lmfa	Rental Income From Real Estate RentalIncomeFromRealEstate	133000
CY2020	lmfa	Cost Recovery From Real Estate Assets Owned Rent Revenue CostRecoveryFromRealEstateAssetsOwnedRentRevenue	0
CY2021Q4	lmfa	Contingent Obligations ContingentObligations	4600
CY2020Q4	lmfa	Contingent Obligations ContingentObligations	3000
CY2021Q4	us-gaap	Notes Payable NotesPayable	114688
CY2020Q4	us-gaap	Notes Payable NotesPayable	282042
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	114688
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	114688
CY2021	lmfa	Operating Lease Remaining Lease Term OperatingLeaseRemainingLeaseTerm	P1Y
CY2021	lmfa	Lease Expiration Period LeaseExpirationPeriod	P37M
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.065
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	94000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	94000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59969
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160667
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	59969
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68002
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	103646
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68002
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	68002
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	171648
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0655
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0655
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	103646
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	94235
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	68002
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	68002
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3246000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4658000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326178
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.061
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	290238
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-955977
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	35940
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-197796
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	326178
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-1153773
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1126450
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	130403
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1126450
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1023370
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326178
CY2021	lmfa	Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate	0.271
CY2020	lmfa	Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate	0.253
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1445949
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.271
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1024640
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.253
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6678
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.001
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1271
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1126449
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.211
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1023369
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.253
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2020Q4	lmfa	Deferred Tax Liabilities Assets Deferred Expense Capitalized Software DeferredTaxLiabilitiesAssetsDeferredExpenseCapitalizedSoftware	1814
CY2021Q4	lmfa	Deferred Tax Liabilities Assets Deferred Vendor Stock Compensation DeferredTaxLiabilitiesAssetsDeferredVendorStockCompensation	-261323
CY2020Q4	lmfa	Deferred Tax Liabilities Assets Property Plant And Equipment DeferredTaxLiabilitiesAssetsPropertyPlantAndEquipment	2916
CY2021Q4	lmfa	Deferred Income Tax Liabilities Assets DeferredIncomeTaxLiabilitiesAssets	-261323
CY2020Q4	lmfa	Deferred Income Tax Liabilities Assets DeferredIncomeTaxLiabilitiesAssets	4730
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2101401
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3913579
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	669959
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	124876
CY2021Q4	lmfa	Deferred Tax Assets Tax Step Up In Basis Purchase Of Noncontrolling Interest DeferredTaxAssetsTaxStepUpInBasisPurchaseOfNoncontrollingInterest	42529
CY2020Q4	lmfa	Deferred Tax Assets Tax Step Up In Basis Purchase Of Noncontrolling Interest DeferredTaxAssetsTaxStepUpInBasisPurchaseOfNoncontrollingInterest	49950
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	16539
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	33466
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	216284
CY2020	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod	275540
CY2020	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	11.20
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPeriodIncreaseDecrease	201695
CY2020	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustment Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentWeightedAverageGrantDateFairValue	2.30
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	240000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	62.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7702441
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.00
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2718012
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.20
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	20573
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3507790
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4653496
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3246467
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4658226
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8198000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2718012
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.20
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	791857
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	27.25
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7481041
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.03
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	2240000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.50
CY2021	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod	2496612
CY2021	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	4.22
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3953067
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.95
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	100
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	625.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3956827
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.20
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3027
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3760
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	302.55
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	340.40
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0158
CY2021	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Cost Of Equity ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedCostOfEquity	0.1556
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.2342
CY2021Q4	us-gaap	Share Price SharePrice	12.00
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2323100
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	16833000
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	15000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2021	us-gaap	Restructuring Charges RestructuringCharges	240000
CY2020	us-gaap	Restructuring Charges RestructuringCharges	240000

Files In Submission

Name	View Source	Status
0001564590-22-013045-index-headers.html	Edgar Link	pending
0001564590-22-013045-index.html	Edgar Link	pending
0001564590-22-013045.txt	Edgar Link	pending
0001564590-22-013045-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lmfa-10k_20211231.htm	Edgar Link	pending
lmfa-10k_20211231_htm.xml	Edgar Link	completed
lmfa-20211231.xsd	Edgar Link	pending
lmfa-20211231_cal.xml	Edgar Link	unprocessable
lmfa-20211231_def.xml	Edgar Link	unprocessable
lmfa-20211231_lab.xml	Edgar Link	unprocessable
lmfa-20211231_pre.xml	Edgar Link	unprocessable
lmfa-ex211_7.htm	Edgar Link	pending
lmfa-ex311_9.htm	Edgar Link	pending
lmfa-ex312_8.htm	Edgar Link	pending
lmfa-ex321_10.htm	Edgar Link	pending
lmfa-ex322_6.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LMFA
LM FUNDING AMERICA, INC. Stock $lmfa

2021 Q4 Form 10-K Financial Statement

#000156459022013045 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMFA LM FUNDING AMERICA, INC. Stock $lmfa

2021 Q4 Form 10-K Financial Statement

#000156459022013045 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMFA
LM FUNDING AMERICA, INC. Stock $lmfa